Tumor necrosis factor and hiv p24 antigen levels in serum of HIV-infected populations

Journal of Acquired Immune Deficiency Syndromes

Volumn 1, Issue 5, 1988, Pages 436-440

  Reddy, Mohan M ^a   Sorrell, Stephan J ^a   Grieco, Michael H ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

HIV P24 antigen; Interleukin 2 receptor; Tumor necrosis factor; 2 Microglobulin

Indexed keywords

INTERLEUKIN 2; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MICROGLOBULIN; NONHUMAN; SERUM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BETA 2-MICROGLOBULIN; COMPARATIVE STUDY; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV SEROPOSITIVITY; HOMOSEXUALITY; HUMAN; LYMPHATIC DISEASES; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE PROTEINS; SUBSTANCE-RELATED DISORDERS; TUMOR NECROSIS FACTOR;

EID: 0024247501     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239:617-22.
2. De Stefano E, Friedman RM, Friedman-Kein AE, et al. Acid-labile human leukocyte interferon in homosexual men with Kaposi’s sarcoma and lymphadenopathy. J Infect Dis 1982; 146:451-5.
3. Grieco MH, Reddy MM, Kothari HB, Lange M, Klein EB, William D. Elevated beta2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol 1984; 32:174-84.
4. Naylor PH, Friedman-Kien AE, Hersh E, Erdos M, Goldstein AL. Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual, and AIDS serum. Int J Immunopharmacol 1986; 8:667-76.
5. Reddy MM, Grieco MH. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations. AIDS Res Hum Retroviruses 1988; 4:115-20.
6. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316:379-84.
7. Malik S, Balkwill FR. Tumor necrosis factor. Br Med J 1988; 296:1214.
8. Allain J-P, Laurein Y, Paul DA, Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet 1986; 2:1233-6.
9. Von Sydow M, Gaines H, Sonnenborg A, Forsgren M, Pehrson PO, Strannegard O. Antigen detection in primary HIV infection. Br Med J 1988; 296:238-40.
10. Wong GHW, Krowka JF, Stites DP, Goeddel DV. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol 1988; 140:120-4.
11. Lange JMA, Paul DA, Huisman HG, et al. Persistent HIV antigenemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 1986; 293:1459-62.
12. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AS, Gallo RC, Blattner WA. Screening for HTLV-III (AIDS agent) antibodies: specificity, sensitivity and applications. JAMA 1985; 243:221-5.
13. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature (Lond) 1986; 320:584-8.
14. Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988; 9:28-31.
15. Maury CPJ, Teppo A-M. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Merf 1987; 166:1132-7.
16. Mestan J, Digel W, Mittnacht S, et al. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (Lond) 1986; 323:816-22.
17. Wong GHW, Goeddel DV. Tumor necrosis factor alpha and beta inhibit virus replication and synergise with interferons. Nature (Lond) 1986; 323:819-22.
18. Patek PQ, Lin Y, Collins JL. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms. J Immunol 1987; 138:1641-6.
19. Bermudez LEM, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 1988; 140:3006-13.
20. Scuderi P, Sterling KE, Lam KS, et al. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986; 2:1364-5.
21. De Waele M, Thielemans C, Van Camp BKG. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N Engl J Med 1981; 304:460-2.
22. Drew WL, Mills J, Levy J, et al. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med 1985; 103:61-3.
23. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-7.
24. Ammann AJ, Palladino MA, Volberding P, Abrams D, Martin NL, Conant M. Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Clin Immunol 1987; 7:481-5.
25. Bowen PA II, Lobel SA, Caruana RJ, et al. Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med 1988; 108:46-8.
26. Goudsmit J, De Wolf F, Paul DA, et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986; 2:177-80.